Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation Cardiovascular Imaging

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCIMAGING.117.006446PMID 28794139PMCID PMC5555076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

  2017cited by this paper
• Cardiac innervation and sudden cardiac death.

  2015cited by this paper
• Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.

  2014cited by this paper
• Risk Stratification for Sudden Cardiac Death: A Plan for the Future

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• MYOCARDIAL SYMPATHETIC DENERVATION BY PET IDENTIFIES A SUBSTRATE FOR SUDDEN CARDIAC ARREST BUT NOT SLOW VENTRICULAR TACHYCARDIA (≤ 240 BPM) IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY

  2013cited by this paper
• Dissociation of hemodynamic and electrocardiographic indexes of myocardial ischemia in pigs with hibernating myocardium and sudden cardiac death.

  2013cited by this paper
• High‐Risk Electrocardiographic Parameters are Ubiquitous in Patients with Ischemic Cardiomyopathy

  2012cited by this paper
• The effect of comorbidity on the competing risk of sudden and nonsudden death in an ambulatory heart failure population.

  2011cited by this paper
• Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy.

  2011cited by this paper
• Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease.

  2011cited by this paper
• Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.

  2009cited by this paper
• Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

  2008cited by this paper
• Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study

  2008cited by this paper
• Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model

  2007cited by this paper
• Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

  2007cited by this paper
• Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality

  2006cited by this paper
• Brief sympathetic activation precedes the development of ventricular tachycardia and ventricular fibrillation in hibernating myocardium.

  2006cited by this paper
• Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods.

  2006cited by this paper
• Standardized Risk and Description of Results from Multivariable Modeling of a Binary Response

  2006cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

  2004cited by this paper
• Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death.

  2004cited by this paper
• The adult patient with native coarctation of the aorta: balloon angioplasty or primary stenting?

  2003cited by this paper
• Mode of death in heart failure: findings from the ATLAS trial

  2003cited by this paper
• B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure

  2002cited by this paper
• B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure

  2002cited by this paper
• Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.

  2002cited by this paper
• Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.

  2002cited by this paper
• Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.

  2000cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper

• Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia

  2026cites this paper
• Noradrenergic and cholinergic innervation of the normal human heart and changes associated with cardiomyopathy

  2025cites this paper
• Bayliss Starling Prize Lecture 2023: Neuropeptide‐Y being ‘unsympathetic’ to the broken hearted

  2024cites this paper
• Sympathetic structural and electrophysiological remodeling in a rabbit model of reperfused myocardial infarction

  2024cites this paper
• Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19.

  2023cites this paper
• Incremental Value of Right Ventricular Outflow Tract Diameter in Risk Assessment of Chronic Heart Failure Patients with Implantable Cardioverter Defibrillators: Development of RVOTD-ICD Benefit Score in Real-World Setting

  2023cites this paper
• Cardiac imaging for the prediction of sudden cardiac arrest in patients with heart failure

  2023cites this paper
• Autonomic control of ventricular function in health and disease: current state of the art

  2023cites this paper
• Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators

  2022cites this paper
• Cardiac sympathetic innervation and mortality risk scores in patients with heart failure

  2022cites this paper
• Myocardial Denervation and Left Ventricular Volume Predict Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.

  2022cites this paper
• Does Quantification of [11C]meta-hydroxyephedrine and [13N]ammonia Kinetics Improve Risk Stratification in Ischemic Cardiomyopathy

  2021cites this paper
• PET and SPECT Evaluation of Viable Dysfunctional Myocardium

  2021cites this paper
• Study on Risk Factors for Death from Cardiomyopathy and Effectiveness of Health Information Management

  2021cites this paper
• Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy

  2021cites this paper
• Molecular Imaging Using Cardiac PET/CT: Opportunities to Harmonize Diagnosis and Therapy

  2021cites this paper
• Obese cardiogenic arrest survivors with significant coronary artery disease had worse in-hospital mortality and neurological outcomes

  2020cites this paper
• Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.

  2020cites this paper
• Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives.

  2020cites this paper
• Reproducible Quantification of Regional Sympathetic Denervation with [11C]meta-Hydroxyephedrine PET Imaging

  2020cites this paper
• Cardiac software repeatability beyond correlations: Clinical outcomes matter

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• Optical Interrogation of Sympathetic Neuronal Effects on Macroscopic Cardiomyocyte Network Dynamics

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

  2020cites this paper
• Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers

  2020cites this paper
• Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use

  2020cites this paper
• Adrenergic supersensitivity and impaired neural control of cardiac electrophysiology following regional cardiac sympathetic nerve loss

  2020cites this paper
• Fluorine-18-Labeled Fluorescent Dyes for Dual-Mode Molecular Imaging

  2020cites this paper
• Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• Treatment of ventricular arrhythmias: What's New?

  2019cites this paper
• Reliable quantification of myocardial sympathetic innervation and regional denervation using [11C]meta-hydroxyephedrine PET

  2019cites this paper
• Structural and Physiological Imaging to Predict the Risk of Lethal Ventricular Arrhythmias and Sudden Death.

  2019influential citation
• Optical interrogation of sympathetic neuronal effects on macroscopic cardiac monolayer dynamics

  2019cites this paper
• Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target

  2019cites this paper
• β-Adrenergic Receptor Stimulation and Alternans in the Border Zone of a Healed Infarct: An ex vivo Study and Computational Investigation of Arrhythmogenesis

  2019cites this paper
• New Concepts in Sudden Cardiac Arrest to Address an Intractable Epidemic: JACC State-of-the-Art Review.

  2019cites this paper
• The role of heart rate variability, heart rate turbulence, and deceleration capacity in predicting cause-specific mortality in chronic heart failure.

  2019cites this paper
• Editorial commentary: Is it still important to evaluate patients with ischemic cardiomyopathy for viable dysfunctional myocardium prior to myocardial revascularization?

  2018cites this paper
• First-in-Human Studies of [18F] Fluorohydroxyphenethylguanidines: Positron Emission Tomography Radiotracers for Quantifying Regional Cardiac Sympathetic Nerve Density

  2018cites this paper
• First-inHuman Studies of [ 18 F ] Fluorohydroxyphenethylguanidines Positron Emission Tomography Radiotracers for Quantifying Regional Cardiac Sympathetic Nerve Density

  2018cites this paper
• Risk Stratification and Sudden Cardiac Death: Is It Time to Include Autonomic Variables?

  2017cites this paper
• American perspective: Comparing the AHA/ACC and ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

  2017cites this paper